Specific and artifactual labeling in the rat spinal cord and medulla after injection of monosynaptic retrograde tracers into the diaphragm.
The use of fluorescent dyes has been a major improvement for paths tracing studies. However, these tracers present different properties and have to be chosen carefully. The present study compares the ability of different tracers to specifically label phrenic motoneurons (PMNs) innervating the rat diaphragm. The administration of fluorogold (FG) from the transected phrenic nerve specifically labeled PMNs in the ipsilateral spinal cord. However, when FG was injected into one hemidiaphragm, in addition with ipsilateral PMNs, a less intense artifactual labeling was observed in the spinal cord (mainly in contralateral PMNs) and in the medulla oblongata (mainly in the area postrema and cranial motor nuclei). Similar results were observed using horseradish peroxidase, while no labeling was observed after injection of nuclear yellow or diamidino yellow into the diaphragm. By contrast, the dextran amine fluororuby (FR) and the carbocyanine DiAsp selectively and exclusively labeled ipsilateral PMNs 2 or 3 weeks after injection into the diaphragm, respectively. The lipophilic properties of DiAsp and the high molecular weight of FR may prevent their diffusion to adjacent tissues and into the blood stream which seems to account for the artifactual labeling observed with the other tracers. The higher homogeneity and quality of the labeling observed with FR compared to DiAsp make it the most appropriate tracer for the specific monosynaptic fluorescent labeling of PMNs after injection into the diaphragm.
Boulenguez
Pascale
P
Laboratoire de Physiologie Neurovégétative (UMR CNRS 6153, INRA 1147), Université Paul Cézanne (Aix-Marseille III), Marseille, France. pascale.boulenguez@dpm.cnrs-mrs.fr
Gestreau
Christian
C
Vinit
Stéphane
S
Stamegna
Jean-Claude
JC
Kastner
Anne
A
Gauthier
Patrick
P
D000578:Amidines / Q000378:metabolism; D000818:Animals; D016477:Artifacts; D001370:Axonal Transport / Q000187:drug effects / Q000502:physiology; D001562:Benzimidazoles / Q000378:metabolism; D003911:Dextrans / Q000378:metabolism; D003964:Diaphragm / Q000294:innervation* / Q000502:physiology; D004058:Diffusion / Q000187:drug effects; D004525:Efferent Pathways / Q000166:cytology* / Q000502:physiology; D005260:Female; D005456:Fluorescent Dyes / Q000378:metabolism*; D006735:Horseradish Peroxidase / Q000378:metabolism; D008526:Medulla Oblongata / Q000166:cytology* / Q000502:physiology; D008563:Membrane Lipids / Q000378:metabolism; D008970:Molecular Weight; D010791:Phrenic Nerve / Q000166:cytology / Q000502:physiology; D011726:Pyridinium Compounds / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D012235:Rhodamines / Q000378:metabolism; D013116:Spinal Cord / Q000166:cytology* / Q000502:physiology; D013194:Staining and Labeling / Q000379:methods*; D013266:Stilbamidines / Q000378:metabolism; D013569:Synapses / Q000187:drug effects / Q000378:metabolism; D000096926:Benzenesulfonamides
D000578:Amidines; D001562:Benzimidazoles; D003911:Dextrans; D005456:Fluorescent Dyes; D006735:Horseradish Peroxidase; D008563:Membrane Lipids; D011726:Pyridinium Compounds; D012235:Rhodamines; D013266:Stilbamidines; C049774:2-hydroxy-4,4'-diamidinostilbene, methanesulfonate salt; C067661:Fluoro-Ruby; C076868:4-(4-dihexadecylaminostyryl)-N-methylpyridium; C036574:nuclear yellow; D000096926:Benzenesulfonamides; C037945:diamidino yellow